Loomis Sayles & Co. has gone all in on Regeneron Pharmaceuticals, boosting its stake by 393,997 shares in Q4. This leap now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback